Article Text

PDF
Efficacy of an inactivated feline panleucopenia virus vaccine against a canine parvovirus isolated from a domestic cat
  1. K. Gamoh, DVM, PhD1,
  2. M. Senda, DVM, PhD1,
  3. Y Inoue, DVM, PhD1 and
  4. O. Itoh, DVM, PhD1
  1. 1National Veterinary Assay Laboratory, 1-15-1, Tokura, Kokubunji, Tokyo, 185-8511, Japan

Abstract

Canine parvovirus type 2a (CPV-2a) and type 2b (CPV-2b) have recently been isolated from cats throughout the world, and CPV-2b strain FP84 has been reported to be virulent in domestic cats. Although live feline panleucopenia virus (FPLV) vaccines protect domestic cats from CPV infection, the efficacy of inactivated FPLV vaccines has not been established. In this study, two domestic cats were vaccinated with a commercial inactivated FPLV vaccine and challenged with CPV-2b strain FP84 isolated from a domestic cat. The cats were protected against CPV-2b strain FP84 infection and their clinical signs were suppressed, although the two unvaccinated cats showed the typical clinical signs of parvovirus infection.

    Statistics from Altmetric.com

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.